ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,051.09
      0.00%
      US Tech 100
      21,191.20
      0.62%
      Dow Jones
      43,828.06
      -0.20%
      Brent Oil
      74.135
      0.00%
      Bitcoin
      101,900.43
      0.44%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Tango Therapeutics Inc (TNGX) Quote

      Tango Therapeutics Inc

      Tango Therapeutics Inc (TNGX)

      NASDAQ
      3.06
      0.21
      (7.37%)
      Closed December 14 4:00PM
      Delayed by 15 minutes
      3.06
      -0.005
      (-0.16%)
      After Hours: 7:23PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      3.06
      Bid
      2.91
      Ask
      3.05
      Volume
      2,784,584
      2.70 Day's Range 3.075
      2.70 52 Week Range 13.005
      Market Cap
      328.699M
      Previous Close
      2.85
      Open
      2.83
      Last Trade
      35
      @
      3.05
      Last Trade Time
      Financial Volume
      $ 8,062,671
      VWAP
      2.8955
      Average Volume (3m)
      1,856,750
      Shares Outstanding
      107,417,818
      Dividend Yield
      -
      PE Ratio
      -3.23
      Earnings Per Share (EPS)
      -0.95
      Revenue
      36.53M
      Net Profit
      -101.74M

      About Tango Therapeutics Inc

      Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.tangotx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNGX. The last closing price for Tango Therapeutics was $2.85. Over the last year, Tango Therapeutics shares have traded in a share price range of $ 2.70 to $ 13.005.

      Tango Therapeutics currently has 107,417,818 shares outstanding. The market capitalization of Tango Therapeutics is $306.14 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -3.23.

      Ask ADVFN Intelligence (AI)

      TNGX Latest News

      More News

      Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

      December 03 2024
      Business Wire

      Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

      Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

      November 27 2024
      Business Wire

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors

      November 20 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 18 2024
      Edgar (US Regulatory)

      Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

      November 07 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 06 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 06 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 06 2024
      Edgar (US Regulatory)

      Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

      – Positive TNG462 clinical activity across multiple tumor types in the phase 1/2 clinical trial, program moving into full development with multiple combination studies – – Clinical collaboration...

      November 06 2024
      Business Wire

      Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program

      – TNG462 demonstrated durable clinical activity across multiple tumor types, including non-small cell lung cancer (NSCLC) and pancreatic cancer, in ongoing phase 1/2 clinical trial, moving into...

      November 06 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.34-103.43.62.811611323.14571397CS
      4-0.725-19.15455746373.7854.222.814704993.66188943CS
      12-5.38-63.74407582948.448.582.718567504.50430036CS
      26-4.49-59.47019867557.5512.0152.713515136.33963683CS
      52-6.49-67.95811518329.5513.0052.79883357.27959469CS
      156-7.98-72.282608695711.0413.032.476971767.26641056CS
      260-6.55-68.15816857449.6118.842.476473107.48239864CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WKEYWISeKey International Holdings AG
      $ 7.84
      (139.02%)
      		75.53M
      IPHAInnate Pharma SA
      $ 3.00
      (93.55%)
      		13.59M
      AVLDirexion Daily AVGO Bull 2X Shares
      $ 33.67
      (48.92%)
      		658.55k
      LOOPLoop Industries Inc
      $ 1.8092
      (47.09%)
      		82.56M
      AVGXDefiance Daily Target 2X Long AVGO ETF
      $ 31.49
      (46.67%)
      		3.55M
      RPTXRepare Therapeutics Inc
      $ 1.765
      (-55.54%)
      		4.7M
      INOInovio Pharmaceuticals Inc New
      $ 2.31
      (-38.56%)
      		9.86M
      XXII22nd Century Group Inc
      $ 0.048
      (-34.69%)
      		42.23M
      FLGCFlora Growth Corporation
      $ 1.30
      (-34.34%)
      		4.14M
      WTOUTime Limited
      $ 0.281
      (-32.74%)
      		3.79M
      NVDANVIDIA Corporation
      $ 134.25
      (-2.25%)
      		228.17M
      SOUNSoundHound AI Inc
      $ 16.905
      (23.66%)
      		158.74M
      TRUGTruGolf Holdings Inc
      $ 0.6794
      (30.93%)
      		138.19M
      RGTIRigetti Computing Inc
      $ 7.155
      (19.85%)
      		122.67M
      AVGOBroadcom Inc
      $ 224.80
      (24.43%)
      		117.74M

      TNGX Discussion

      View Posts
      Monksdream Monksdream 5 months ago
      TNGX under $10
      👍️0
      Monksdream Monksdream 7 months ago
      TNGX under $10
      👍️0
      bikaver bikaver 1 year ago
      Stopped out with small loss.
      👍️0
      bikaver bikaver 1 year ago
      TNGX......Holding up well, but will tumble soon.
      👍️0
      bikaver bikaver 1 year ago
      TNGA.....short @ 8.60 This is the strength that I wanted to see!
      👍️0
      bikaver bikaver 1 year ago
      TNGX.....Studying the TNGX chart this evening. I'll short it at a good sign of strength if the opportunity presents itself tomorrow.
      👍️0
      SmokeSignals SmokeSignals 1 year ago
      up $4>H.C. Wainwright Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
      Barclays Releases a Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
      Goldman Sachs Keeps Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 7, 2023TIPRANKS
      Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business HighlightsAUGUST 7, 2023TIPRANKS
      Tango Therapeutics reports Q2 EPS (23c), consensus (34c)AUGUST 7, 2023TIPRANKS
      👍️0

      Your Recent History

      NASDAQ
      TNGX
      Tango Therapeutics
      Delayed Upgrade Clock